Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
about
Notch Signaling in Neuroendocrine TumorsCellular and molecular biology of small cell lung cancer: an overviewResveratrol and cancer: Challenges for clinical translationProgression and metastasis of lung cancerNrf2 and Notch Signaling in Lung Cancer: Near the CrossroadGoblet cell carcinoids of the appendix: Tumor biology, mutations and management strategiesMedullary thyroid carcinoma: targeted therapies and future directionsNotch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.Notch-1 and Ki-67 receptor as predictors for the recurrence and prognosis of Kimura's disease.Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.Valproic acid induces Notch1 signaling in small cell lung cancer cellsMulti-targeted approach in the treatment of thyroid cancer.Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cellsIdentification of small molecule Hes1 modulators as potential anticancer chemotherapeutics.Signaling mechanisms in neuroendocrine tumors as targets for therapy.A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivoThiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivoNotch signaling proteins: legitimate targets for cancer therapy.Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method.A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasisExpression of the active Notch1 decreases MTC tumor growth in vivo.Overexpression of Notch1 is associated with the progression of cervical cancer.Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling.The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma.Potential Therapeutic Role of Z-Isochaihulactone in Lung Cancer through Induction of Apoptosis via Notch Signaling.Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumorsPediatric Medullary Thyroid CarcinomaHistone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cellsHighly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics.Clinicopathologic characteristics of colonic carcinoid tumorsTautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.Notch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors.Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumorsCurrent understanding and management of medullary thyroid cancer.The AKT1/NF-kappaB/Notch1/PTEN axis has an important role in chemoresistance of gastric cancer cellsSuberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
P2860
Q26752380-5B20504E-EEC6-48AF-94DB-31C1D7FBEC57Q26767029-672EA9B2-D958-4D80-87B2-52C3BACFBB0EQ27015712-3049B5B3-9E39-48A9-A626-920E62D42827Q28066865-4827568F-26CA-4C11-BF4A-B5F66713680BQ28066915-A072620E-A559-49F2-A80E-4BC76CDBC42BQ28073184-D604C343-70C6-4F08-AE09-FAF60853585BQ33557376-4E14E6F5-CE31-46C5-9461-8DD99201F0F9Q33680709-7CD923B8-7408-4D9D-B186-D6C2567E2A40Q33802961-D9B72AB1-BFE7-4C04-84FD-EAEF80233A59Q33804934-F1B4368F-BBCF-4B38-B7F6-D14D77A79701Q33976203-DCF89261-1252-40E2-AB59-D6B1C1787F8AQ33982413-1C11B2E5-EDF0-4128-9C3E-EF8A4224029BQ33998266-5449FA10-9B98-4BA6-9CD7-0AEFFD9889D1Q34420344-F1460A24-7CD7-40F5-977C-16F07115D8D2Q34447484-20DC3F2B-0688-47E7-BB29-2E8E0F0F3198Q34491149-78FE4854-EB11-4099-B87C-8A727B9C73B1Q34734429-83F7F52D-2884-4686-81AC-9C6829033B00Q34982347-67ED8B12-F571-4435-A482-2341F66EE470Q35050983-B807357C-550B-41CE-B053-C039394676A2Q35064499-377E2FDD-00A5-4CAE-A82B-25E460458B0FQ35146386-E10127D9-069B-4E5E-955E-6411A3C349A6Q35169079-53831D9F-F8C8-4EAD-97A8-D1E1AA427684Q35758978-EFB49685-93DD-4FC6-8537-5A2AFAB1078DQ35776244-5878C423-5EA5-4484-A803-2AF4880881CCQ36019650-45F32FE4-C0D9-477C-AE99-D20818CCBB0EQ36048511-B1B56B48-900F-4DAB-9BFD-33A40C669BFAQ36070575-7AB57E8E-3ED9-4DF8-B261-0078664DEB15Q36291949-53715F33-34EE-4E19-954B-DE0B6B7DF024Q36447011-E0DA0F2F-549D-4A7F-9FF9-B98B30EC3CC2Q36715586-81496230-6754-4DAE-84C6-83B6AE795268Q37089077-4D1FBF4B-62AC-4E22-ACB7-8C6D87D4329FQ37106973-4E050D33-7386-4C63-A15F-E469454E378CQ37138310-6B47F813-CC71-4816-8246-DBC38E39415CQ37161813-3095C0DD-14D8-4851-8CEA-8B6210F6B7C5Q37171078-03CB1E6B-36A5-4526-AE77-889BB6C90B56Q37179117-4A8FD422-4C61-410C-88A2-C89990C56846Q37247181-8C20FB38-D3BC-42C4-8C4C-CE89AB91088AQ37299680-B35B851A-15C3-4E20-AC10-B540343F19EDQ37332674-A87E0748-12B8-49C3-95C6-B5A30883FCC2Q37339815-68A9BD84-CF40-413A-9DF1-A11F656DF7F7
P2860
Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
@en
type
label
Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
@en
prefLabel
Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
@en
P1433
P1476
Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors
@en
P2093
Herbert Chen
P304
P356
10.1634/THEONCOLOGIST.12-5-535
P577
2007-05-01T00:00:00Z